ArticleCase reports in oncology

Factors Affecting Therapeutic Effects in 17 Patients with Advanced Hepatocellular Carcinoma Who Were Treated with Sorafenib for More than 12 Months.

Kazuhiro Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.